Cardiac Rhythm Management Devices Market Size

  • Report ID: 6044
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Cardiac Rhythm Management Devices Market Size

Cardiac Rhythm Management Devices Market size was valued at USD 17.88 billion in 2024 and is likely to cross USD 38.61 billion by 2037, registering more than 6.1% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of cardiac rhythm management devices is estimated at USD 18.75 billion.

The need for efficient treatment alternatives has increased due to the rising prevalence of cardiovascular disorders, including atrial fibrillation, cardiac arrhythmias, and heart failure. It was observed by National Library of Medicine, that 10,951,403 fatalities due to CVD (heart disease, 16.9% stroke) happened between 2010 and 2022. The aging population, which is more prone to heart-related conditions, has also aided in the cardiac rhythm management devices market growth. The development of the market has also been significantly aided by technological developments. The accuracy and effectiveness of these devices have increased owing to advancements in wireless communication, smart algorithms, and device downsizing. The treatment of cardiac rhythm abnormalities has also been completely transformed by the advent of pacemakers, cardiac resynchronization therapy (CRT) devices, and implantable cardioverter-defibrillators (ICDs).


Cardiac Rhythm Management Devices Market
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 6044
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of cardiac rhythm management devices is estimated at USD 18.75 billion.

The cardiac rhythm management devices market size was valued at USD 17.88 billion in 2024 and is likely to cross USD 38.61 billion by 2037, registering more than 6.1% CAGR during the forecast period i.e., between 2025-2037. The aging population, which is more prone to heart-related conditions will propel the market growth.

North America industry is predicted to account for largest revenue share of 36% by 2037, influenced by well-developed healthcare infrastructure in the region

The major players in the market include Vitatron Holding B.V., Medtronic, Biotronik, Abbott, ABIOMED, Stryker Corporation, Amiitalia., © BPL Medical Technologies, OSYPKA MEDICAL, MicroPort Scientific Corporation
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample